Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
Abstract Background The optimal adjuvant endocrine therapy (ET) in hormone receptor positive (HR+) and human epidermal growth factor receptor 2 positive (HER2+) premenopausal breast cancer (BC) remains unclear. Moreover, the benefit and clinical indications of ovarian suppression (OS) is poorly eluc...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2024-06-01
|
| Serier: | Cancer Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/cam4.7317 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
